Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Tolerability and Clinical Effectiveness of Letermovir in Heart Transplantation

NCT04904614 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT04904614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04904614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Tolerability and Clinical Effectiveness of Letermovir in Heart Transplantation
Lead sponsor
Tufts Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 5, 2022
Completion date
January 14, 2025
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiviral toxicity, cytomegalovirus disease, cytomegalovirus infections, heart transplant infection, neutropenia